文献速递冠心病心力衰竭与心肌病

残余SYNTAX评分对心源性休克患者的预测价值

Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

基于CULPRIT-SHOCK试验,在587例多支病变合并心肌梗死相关心源性休克患者中评估残余SYNTAX评分(rSS)的预后价值。结果显示rSS中位数9.0,多支PCI策略下仅25.2%达到完全血运重建,rSS与30天和1年死亡率独立相关。

要点

  • 多支PCI策略下仅约四分之一患者达到完全血运重建。
  • rSS每增加10单位,30天死亡风险独立增高49%。
  • rSS每增加10单位,1年死亡风险独立增高52%。

核心结论

  • 在多支病变合并心肌梗死相关心源性休克患者中,残余SYNTAX评分与早期和晚期死亡率独立相关。

研究设计与样本

  • 基于CULPRIT-SHOCK试验的回顾性分析,纳入587例有rSS数据的多支病变合并心肌梗死相关心源性休克患者。
  • rSS由中心核心实验室评估,按三分位分为4个亚组并单独分析rSS=0(完全血运重建)患者。

主要发现

  • rSS中位数为9.0(四分位距3.0至17.0)。
  • rSS=0、0<rSS≤5、5<rSS≤14和rSS>14的患者分别为102例(17.4%)、100例(17.0%)、196例(33.4%)和189例(32.2%)。
  • 多支PCI策略和仅罪犯病变PCI策略下完全血运重建率分别为25.2%(95%CI 20.3%至30.5%)和9.3%(95%CI 6.2%至13.3%)。
  • 多因素校正后,rSS与30天死亡率独立相关(每10单位校正OR 1.49;95%CI 1.11至2.01)。
  • 多因素校正后,rSS与1年死亡率独立相关(每10单位校正OR 1.52;95%CI 1.11至2.07)。

临床怎么用

  • 在心肌梗死相关心源性休克合并多支病变患者中,可用rSS评估PCI术后残余狭窄负荷以辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In hemodynamically stable patients, complete revascularization (CR) following percutaneous coronary intervention (PCI) is associated with a better prognosis in chronic and acute coronary syndromes. OBJECTIVES: This study sought to assess the extent, severity, and prognostic value of remaining coronary stenoses following PCI, by using the residual SYNTAX score (rSS), in patients with cardiogenic shock (CS) related to myocardial infarction (MI). METHODS: The CULPRIT-SHOCK (Culprit Lesion Only Percutaneous Coronary Intervention [PCI] Versus Multivessel PCI in Cardiogenic Shock) trial compared a multivessel PCI (MV-PCI) strategy with a culprit lesion-only PCI (CLO-PCI) strategy in patients with multivessel coronary artery disease who presented with MI-related CS. The rSS was assessed by a central core laboratory. The study group was divided in 4 subgroups according to tertiles of rSS of the participants, thereby isolating patients with an rSS of 0 (CR). The predictive value of rSS for the 30-day primary endpoint (mortality or severe renal failure) and for 30-day and 1-year mortality was assessed using multivariate logistic regression. RESULTS: Among the 587 patients with an rSS available, the median rSS was 9.0 (interquartile range: 3.0 to 17.0); 102 (17.4%), 100 (17.0%), 196 (33.4%), and 189 (32.2%) patients had rSS = 0, 0 < rSS ≤5, 5 < rSS ≤14, and rSS >14, respectively. CR was achieved in 75 (25.2%; 95% confidence interval [CI]: 20.3% to 30.5%) and 27 (9.3%; 95% CI: 6.2% to 13.3%) of patients treated using the MV-PCI and CLO-PCI strategies, respectively. After multiple adjustments, rSS was independently associated with 30-day mortality (adjusted odds ratio per 10 units: 1.49; 95% CI: 1.11 to 2.01) and 1-year mortality (adjusted odds ratio per 10 units: 1.52; 95% CI: 1.11 to 2.07). CONCLUSIONS: Among patients with multivessel disease and MI-related CS, CR is achieved only in one-fourth of the patients treated using an MV-PCI strategy. and the residual SYNTAX score is independently associated with early and late mortality.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Barthélémy O, Rouanet S, Brugier D, et al. Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock. J Am Coll Cardiol. 2021. PMID: 33446307. doi:10.1016/j.jacc.2020.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。